NCYT.LSE Novacyt

Healthcare Health Care Equipment & Supplies London Exchange
0.3510 GBX
Close of Nov 3, 2026
26.60 86.00
Market cap
GBX 25.5M
P/E
-
P/B
1.41x
ROE
-92.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is NCYT.LSE undervalued?

Graham number

The Graham number of Novacyt cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Novacyt fundamental analysis

No fundamental analysis for Novacyt yet.

Novacyt stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Novacyt

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, a…

Full company profile